OPKO Health, Inc. (OPK)
NASDAQ: OPK · IEX Real-Time Price · USD
1.490
-0.030 (-1.97%)
At close: Jul 19, 2024, 4:00 PM
1.510
+0.020 (1.34%)
Pre-market: Jul 22, 2024, 7:08 AM EDT
OPKO Health Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for OPKO Health stock have an average target of 2.50, with a low estimate of 1.50 and a high estimate of 3.00. The average target predicts an increase of 67.79% from the current stock price of 1.49.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for OPKO Health stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Maintains $5 → $3 | Buy | Maintains | $5 → $3 | +101.34% | Jul 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +101.34% | May 8, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $1.5 | Buy | Maintains | $1.5 | +0.67% | Apr 1, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $5 | Buy | Reiterates | $5 | +235.57% | Apr 1, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $3 | Strong Buy | Reiterates | $3 | +101.34% | Feb 28, 2024 |
Financial Forecast
Revenue This Year
718.12M
from 863.50M
Decreased by -16.84%
Revenue Next Year
753.49M
from 718.12M
Increased by 4.93%
EPS This Year
-0.38
from -0.25
EPS Next Year
-0.23
from -0.38
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 784.0M | 868.8M | 938.0M |
| Avg | 718.1M | 753.5M | 863.1M |
| Low | 662.1M | 645.2M | 799.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -9.2% | 21.0% | 24.5% |
| Avg | -16.8% | 4.9% | 14.5% |
| Low | -23.3% | -10.2% | 6.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.29 | -0.03 | 0.04 |
| Avg | -0.38 | -0.23 | -0.06 |
| Low | -0.48 | -0.32 | -0.16 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.